The GI Cancer Institute and the AGITG work together to raise funds and awareness of gastro-intestinal (GI) cancer and clinical trials, and to develop and deliver rigorous best practice clinical trials for Gastro-Intestinal cancer patients.Since 1991, our key priority has been to undertake research that is centred on patient care and to improve medical care and practice in the treatment of GI cancer. Our clinical trials allow us to find better ways to treat GI cancers. This has seen improvement in both the life expectancy and quality of life of people diagnosed with these cancers over the last 30 years.GI cancers include those of the oesophagus, stomach, liver, gall bladder, pancreas, small intestine, bowel and anus. GI cancers are the most common form of cancer, directly affecting more than 28,600 Australians each year and claiming a devastating 39 lives each day.The multi-disciplinary AGITG membership encompasses medical oncologists, radiation oncologists, surgeons, statisticians, data managers, allied health care professionals and consumers. The GI Cancer Institute is a not-for-profit organisation that saves lives by funding GI cancer research, conducted by the AGITG. Through regular appeals, community fundraising events, bequests, in memory giving, and philanthropic support, the GI Cancer Institute funds small-scale AGITG trials to improve outcomes for people with GI cancer.

Website: gicancer.org.au

Employees: 20 - 49

HQ:

Location: Sydney, New South, AU

Revenue: 2.5 - 5 Million

The GI Cancer Institute is a non-profit organization based in Sydney, Australia, dedicated to raising funds and awareness for gastro-intestinal (GI) cancer research. In collaboration with the Australasian Gastro-Intestinal Trials Group (AGITG), the institute works to improve medical care and practice in the treatment of GI cancer. The organization's mission is to save lives by funding GI cancer research conducted by the AGITG, which has led to improved life expectancy and quality of life for patients diagnosed with these cancers over the past 30 years. The GI Cancer Institute funds small-scale AGITG trials to improve outcomes for people with GI cancer. The organization's multi-disciplinary membership includes medical oncologists, radiation oncologists, surgeons, statisticians, data managers, allied health care professionals, and consumers. The institute's efforts have directly affected over 28,600 Australians diagnosed with GI cancer each year, and have helped to claim 39 lives daily. The GI Cancer Institute relies on regular appeals, community fundraising events, bequests, in-memory giving, and philanthropic support to fund its research. The organization's website, gicancer.org.au, provides information on their efforts, clinical trials, and how to support their mission. The institute is also active on LinkedIn and Facebook, where they share updates and information on their work. As a non-profit organization, the GI Cancer Institute relies on the support of the community to continue its life-saving research. By funding clinical trials and raising awareness of GI cancer, the institute is working towards a future where fewer lives are lost to this devastating disease.

The GI Cancer Institute and AGITG are organizations that work together to help people with gastro-intestinal (GI) cancer. They raise money and awareness for clinical trials, which are research studies that help doctors find better ways to treat GI cancer. These organizations also work to improve patient care and medical practices. GI cancer includes cancer of the esophagus, stomach, liver, gall bladder, pancreas, small intestine, bowel, and anus. Unfortunately, GI cancer is very common and affects many people in Australia, causing 39 deaths every day. The AGITG has a team of doctors, nurses, and other healthcare professionals who work together to conduct research and improve patient care. The GI Cancer Institute is a non-profit organization that raises money for GI cancer research through donations, fundraising events, and other means. They use this money to fund small-scale clinical trials that can help improve the lives of people with GI cancer. Over the past 30 years, the work of these organizations has led to better treatments and longer life expectancy for people with GI cancer. They continue to work towards finding even better treatments and improving patient care.